乐普医疗：下属公司注射用交联透明质酸钠凝胶获NMPA注册批准

Core Viewpoint - Lepu Medical (300003.SZ) announced that its subsidiary, Sichuan Xingtai Pule Medical Technology Co., Ltd., has received approval from the National Medical Products Administration for its self-developed injectable cross-linked sodium hyaluronate gel, which is intended for use in correcting moderate to severe nasolabial folds [1] Group 1 - The newly approved product is designed for injection into the mid to deep layers of dermal tissue in the nasolabial fold area [1] - This approval enhances the company's product matrix in the dermatology field, indicating a strategic expansion of its offerings [1] - The market performance of the new product post-launch may be influenced by various factors, leading to uncertainty regarding its impact on the company's future performance [1]